{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:25:21Z","timestamp":1777044321533,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00106-026-01757-x","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:14:34Z","timestamp":1774959274000},"page":"282-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunologie des Alterns bei Kopf-Hals-Karzinomen","Immunology of aging in head and neck cancer"],"prefix":"10.1007","volume":"74","author":[{"given":"C. H. L.","family":"K\u00fcrten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Peis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Boosfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Peis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"1757_CR1","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.arr.2010.06.004","volume":"10","author":"A Agrawal","year":"2011","unstructured":"Agrawal\u00a0A, Gupta\u00a0S (2011) Impact of aging on dendritic cell functions in humans. Ageing Res Rev 10:336\u2013345","journal-title":"Ageing Res Rev"},{"key":"1757_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102540","volume":"101","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady\u00a0A, Pratico\u00a0D, Tang\u00a0D et\u00a0al (2024) Immunosenescence and inflammaging: Mechanisms and role in diseases. Ageing Res Rev 101:102540","journal-title":"Ageing Res Rev"},{"key":"1757_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1080\/14737140.2022.2139242","volume":"22","author":"T Alexa-Stratulat","year":"2022","unstructured":"Alexa-Stratulat\u00a0T, Pavel-Tanasa\u00a0M, Cianga\u00a0VA, Antoniu\u00a0S (2022) Immune senescence in non-small cell lung cancer management: therapeutic relevance, biomarkers, and mitigating approaches. Expert Rev Anticancer Ther 22:1197\u20131210","journal-title":"Expert Rev Anticancer Ther"},{"key":"1757_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2022.09.009","volume":"14","author":"C Becherini","year":"2023","unstructured":"Becherini\u00a0C, Banini\u00a0M, Desideri\u00a0I et\u00a0al (2023) Clinical outcome of nivolumab in older and frail patients with recurrent\/metastatic head and neck squamous cell carcinoma. J\u00a0Geriatr Oncol 14:101380","journal-title":"J Geriatr Oncol"},{"key":"1757_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cells11061017","volume":"11","author":"B A","year":"2022","unstructured":"A\u00a0B, M\u00a0R, G\u00a0Z et\u00a0al (2022) Aging of the immune system: Focus on natural killer cells phenotype and functions. Cells 11:1017","journal-title":"Cells"},{"key":"1757_CR6","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness\u00a0B, Harrington\u00a0KJ, Greil\u00a0R et\u00a0al (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet 394:1915\u20131928","journal-title":"Lancet"},{"key":"1757_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.857994","volume":"12","author":"F Chen","year":"2022","unstructured":"Chen\u00a0F, Gong\u00a0X, Xia\u00a0M et\u00a0al (2022) The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. Front Oncol 12:857994","journal-title":"Front Oncol"},{"key":"1757_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106659","volume":"149","author":"L Chen","year":"2024","unstructured":"Chen\u00a0L, Lin\u00a0J, Wen\u00a0Y et\u00a0al (2024) A senescence-related lncRNA signature predicts prognosis and reflects immune landscape in HNSCC. Oral Oncol 149:106659","journal-title":"Oral Oncol"},{"key":"1757_CR9","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"Ferris\u00a0RL, Blumenschein\u00a0G Jr, Fayette\u00a0J et\u00a0al (2016) Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N\u00a0Engl J Med 375:1856\u20131867","journal-title":"N Engl J Med"},{"key":"1757_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi\u00a0C, Bonaf\u00e8\u00a0M, Valensin\u00a0S et\u00a0al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244\u2013254","journal-title":"Ann N Y Acad Sci"},{"key":"1757_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-cellbio-011620-034148","volume":"36","author":"D Frasca","year":"2020","unstructured":"Frasca\u00a0D, Diaz\u00a0A, Romero\u00a0M et\u00a0al (2020) B cell immunosenescence. Annu Rev Cell Dev Biol 36:551\u2013574","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1757_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-0174-7","volume":"17","author":"SS Jeske","year":"2020","unstructured":"Jeske\u00a0SS, Schuler\u00a0PJ, Doescher\u00a0J et\u00a0al (2020) Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma. Immun Ageing 17:3","journal-title":"Immun Ageing"},{"key":"1757_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153834","volume":"15","author":"MF van der Kamp","year":"2023","unstructured":"van der Kamp\u00a0MF, Hiddingh\u00a0E, de Vries\u00a0J et\u00a0al (2023) Association of tumor microenvironment with biological and chronological age in head and neck cancer. Cancers (Basel) 15:3834","journal-title":"Cancers (Basel)"},{"key":"1757_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79130-7","volume":"14","author":"Y Kasahara","year":"2024","unstructured":"Kasahara\u00a0Y, Saijo\u00a0K, Ueta\u00a0R et\u00a0al (2024) Pretreatment neutrophil-lymphocyte ratio as a prognostic factor in recurrent\/metastatic head and neck cancer treated with pembrolizumab. Sci Rep 14:28255","journal-title":"Sci Rep"},{"key":"1757_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100577","volume":"7","author":"CM Kim","year":"2022","unstructured":"Kim\u00a0CM, Lee\u00a0JB, Shin\u00a0SJ et\u00a0al (2022) The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression. ESMO Open 7:100577","journal-title":"ESMO Open"},{"key":"1757_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cell.2005.01.027","volume":"120","author":"TBL Kirkwood","year":"2005","unstructured":"Kirkwood\u00a0TBL (2005) Understanding the odd science of aging. Cell 120:437\u2013447","journal-title":"Cell"},{"key":"1757_CR17","first-page":"S167","volume":"103","author":"CHL K\u00fcrten","year":"2024","unstructured":"K\u00fcrten\u00a0CHL, Ferris\u00a0RL (2024) Neoadjuvant immunotherapy for head and neck squamous cell carcinoma. Laryngorhinootologie 103:S167\u2013S187","journal-title":"Laryngorhinootologie"},{"key":"1757_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27619-4","volume":"12","author":"CHL K\u00fcrten","year":"2021","unstructured":"K\u00fcrten\u00a0CHL, Kulkarni\u00a0A, Cillo\u00a0AR et\u00a0al (2021) Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun 12:7338","journal-title":"Nat Commun"},{"key":"1757_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1577901","volume":"15","author":"CHL K\u00fcrten","year":"2025","unstructured":"K\u00fcrten\u00a0CHL, Sivakumar\u00a0V, Wa\u00dfenberg\u00a0S et\u00a0al (2025) Pre-treatment anemia in head and neck cancer: risk factors, subtypes, and survival outcomes. Front Oncol 15:1577901","journal-title":"Front Oncol"},{"key":"1757_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68991-3","volume":"10","author":"S Lee","year":"2020","unstructured":"Lee\u00a0S, Kim\u00a0DW, Kwon\u00a0S et\u00a0al (2020) Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8th edition of AJCC staging system. Sci Rep 10:12111","journal-title":"Sci Rep"},{"key":"1757_CR21","doi-asserted-by":"publisher","first-page":"985","DOI":"10.18632\/aging.205346","volume":"16","author":"YC Lee","year":"2023","unstructured":"Lee\u00a0YC, Nam\u00a0Y, Kim\u00a0M et\u00a0al (2023) Prognostic significance of senescence-related tumor microenvironment genes in head and neck squamous cell carcinoma. Aging (Albany NY) 16:985\u20131001","journal-title":"Aging (Albany NY)"},{"key":"1757_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.18632\/aging.101414","volume":"10","author":"ME Levine","year":"2018","unstructured":"Levine\u00a0ME, Lu\u00a0AT, Quach\u00a0A et\u00a0al (2018) An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY) 10:573\u2013591","journal-title":"Aging (Albany NY)"},{"key":"1757_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1556\/EuJMI-D-14-00035","volume":"5","author":"E Linehan","year":"2015","unstructured":"Linehan\u00a0E, Fitzgerald\u00a0DC (2015) Ageing and the immune system: focus on macrophages. Eur J Microbiol Immunol (Bp) 5:14\u201324","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"1757_CR24","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1038\/s41591-025-03873-7","volume":"31","author":"N Liu","year":"2025","unstructured":"Liu\u00a0N, Wu\u00a0J, Deng\u00a0E et\u00a0al (2025) Immunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results. Nat Med 31:3047\u20133061","journal-title":"Nat Med"},{"key":"1757_CR25","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn\u00a0C, Blasco\u00a0MA, Partridge\u00a0L et\u00a0al (2013) The hallmarks of aging. Cell 153:1194\u20131217","journal-title":"Cell"},{"key":"1757_CR26","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2025.43.16_suppl.e22564","author":"J Ma","year":"2025","unstructured":"Ma\u00a0J, Zhong\u00a0W, Bidadi\u00a0B et\u00a0al (2025) Incidence and overall survival of head and neck squamous cell carcinoma in the US: SEER 17, 2018\u20132021. J\u00a0Clin Oncol. https:\/\/doi.org\/10.1200\/jco.2025.43.16_suppl.e22564","journal-title":"J Clin Oncol"},{"key":"1757_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","volume":"22","author":"M Mittelbrunn","year":"2021","unstructured":"Mittelbrunn\u00a0M, Kroemer\u00a0G (2021) Hallmarks of T cell aging. Nat Immunol 22:687\u2013698","journal-title":"Nat Immunol"},{"key":"1757_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","volume":"19","author":"J Nikolich-\u017dugich","year":"2018","unstructured":"Nikolich-\u017dugich\u00a0J (2018) The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol 19:10\u201319","journal-title":"Nat Immunol"},{"key":"1757_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.exger.2017.10.024","volume":"105","author":"G Pawelec","year":"2018","unstructured":"Pawelec\u00a0G (2018) Age and immunity: What is \u201cimmunosenescence\u201d? Exp Gerontol 105:4\u20139","journal-title":"Exp Gerontol"},{"key":"1757_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-022-02153-9","volume":"17","author":"A R\u00fchle","year":"2022","unstructured":"R\u00fchle\u00a0A, Todorovic\u00a0J, Spohn\u00a0SSK et\u00a0al (2022) Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy. Radiat Oncol 17:181","journal-title":"Radiat Oncol"},{"key":"1757_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.oraloncology.2019.06.017","volume":"96","author":"NF Saba","year":"2019","unstructured":"Saba\u00a0NF, Blumenschein\u00a0G Jr, Guigay\u00a0J et\u00a0al (2019) Nivolumab versus investigator\u2019s choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age. Oral Oncol 96:7\u201314","journal-title":"Oral Oncol"},{"key":"1757_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejca.2021.08.030","volume":"157","author":"K Saleh","year":"2021","unstructured":"Saleh\u00a0K, Auperin\u00a0A, Martin\u00a0N et\u00a0al (2021) Efficacy and safety of immune checkpoint inhibitors in elderly patients (\u2265\u202f70\u00a0years) with squamous cell carcinoma of the head and neck. Eur J Cancer 157:190\u2013197","journal-title":"Eur J Cancer"},{"key":"1757_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1395838","volume":"14","author":"V Salvestrini","year":"2024","unstructured":"Salvestrini\u00a0V, Caini\u00a0S, Scricciolo\u00a0M et\u00a0al (2024) Immunotherapy in elderly head and neck cancer patients: a systematic review and meta-analysis. Front Oncol 14:1395838","journal-title":"Front Oncol"},{"key":"1757_CR34","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/S1470-2045(18)30348-6","volume":"19","author":"E Soto-Perez-de-Celis","year":"2018","unstructured":"Soto-Perez-de-Celis\u00a0E, Li\u00a0D, Yuan\u00a0Y et\u00a0al (2018) Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer. Lancet Oncol 19:e305\u2013e316","journal-title":"Lancet Oncol"},{"key":"1757_CR35","doi-asserted-by":"crossref","unstructured":"Swoboda S, Vanagas R, Altunbulakli C et\u00a0al. (2025) Tumour-infiltrating immune cells in tonsillar cancer: no tissue-level signs of inflammageing in the elderly. Acta Otolaryngol:1\u201310","DOI":"10.1080\/00016489.2025.2575865"},{"key":"1757_CR36","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1002\/hed.25954","volume":"41","author":"LR Teixeira","year":"2019","unstructured":"Teixeira\u00a0LR, Almeida\u00a0LY, Silva\u00a0RN et\u00a0al (2019) Young and elderly oral squamous cell carcinoma patients present similar angiogenic profile and predominance of M2 macrophages: Comparative immunohistochemical study. Head Neck 41:4111\u20134120","journal-title":"Head Neck"},{"key":"1757_CR37","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1200\/JCO.19.00370","volume":"37","author":"JE Tota","year":"2019","unstructured":"Tota\u00a0JE, Best\u00a0AF, Zumsteg\u00a0ZS et\u00a0al (2019) Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals. JCO 37:1538\u20131546","journal-title":"JCO"},{"key":"1757_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1056\/NEJMoa2415434","volume":"393","author":"R Uppaluri","year":"2025","unstructured":"Uppaluri\u00a0R, Haddad\u00a0RI, Tao\u00a0Y et\u00a0al (2025) Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer. N\u00a0Engl J Med 393:37\u201350","journal-title":"N Engl J Med"},{"key":"1757_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/imr.13153","volume":"314","author":"K Van Avondt","year":"2023","unstructured":"Van Avondt\u00a0K, Strecker\u00a0J, Tulotta\u00a0C et\u00a0al (2023) Neutrophils in aging and aging-related pathologies. Immunological Reviews 314:357\u2013375","journal-title":"Immunological Reviews"},{"key":"1757_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.105020","volume":"111","author":"J de Vries","year":"2020","unstructured":"de Vries\u00a0J, Bras\u00a0L, Sidorenkov\u00a0G et\u00a0al (2020) Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer. Oral Oncol 111:105020","journal-title":"Oral Oncol"},{"key":"1757_CR41","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","volume":"25","author":"B Wang","year":"2024","unstructured":"Wang\u00a0B, Han\u00a0J, Elisseeff\u00a0JH, Demaria\u00a0M (2024) The senescence-associated secretory phenotype and its physiological and pathological implications. Nat Rev Mol Cell Biol 25:958\u2013978","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1757_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00915-5","volume":"30","author":"Z Wu","year":"2023","unstructured":"Wu\u00a0Z, Uhl\u00a0B, Gires\u00a0O, Reichel\u00a0CA (2023) A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence. J\u00a0Biomed Sci 30:21","journal-title":"J Biomed Sci"},{"key":"1757_CR43","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1002\/cncr.33641","volume":"127","author":"C Xiao","year":"2021","unstructured":"Xiao\u00a0C, Beitler\u00a0JJ, Peng\u00a0G et\u00a0al (2021) Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study. Cancer 127:3361\u20133371","journal-title":"Cancer"},{"key":"1757_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijrobp.2021.04.002","volume":"111","author":"C Xiao","year":"2021","unstructured":"Xiao\u00a0C, Miller\u00a0AH, Peng\u00a0G et\u00a0al (2021) Association of epigenetic age acceleration with risk factors, survival, and quality of life in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 111:157\u2013167","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1757_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71223","volume":"14","author":"L Xiong","year":"2025","unstructured":"Xiong\u00a0L, Cheng\u00a0J (2025) Cellular senescence and immunosenescence in melanoma: Insights from the tumor microenvironment. Cancer Med 14:e71223","journal-title":"Cancer Med"},{"key":"1757_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145149","volume":"318","author":"Z Xu","year":"2025","unstructured":"Xu\u00a0Z, Xue\u00a0M, Yang\u00a0Y et\u00a0al (2025) Transcriptome-wide gene-age interaction study and multi-omics comprehensive analysis reveals heterogeneous regulation of NLRC4 during aging on HNSCC prognosis and immune microenvironment. Int J Biol Macromol 318:145149","journal-title":"Int J Biol Macromol"},{"key":"1757_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1303132","volume":"13","author":"J Zhang","year":"2023","unstructured":"Zhang\u00a0J, Dai\u00a0S (2023) Prognostic and clinicopathological role of pretreatment systemic immune-inflammation index in patients with oral squamous cell carcinoma: a\u00a0meta-analysis. Front Oncol 13:1303132","journal-title":"Front Oncol"},{"key":"1757_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106632","volume":"148","author":"S Zhang","year":"2024","unstructured":"Zhang\u00a0S, Zheng\u00a0M, Tian\u00a0H et\u00a0al (2024) Are immune checkpoint inhibitors ineffective in treating patients with head and neck squamous cell carcinoma aged 75 years or Older? A Meta-Analysis. Oral Oncol 148:106632","journal-title":"Oral Oncol"},{"key":"1757_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1662464","volume":"13","author":"J Zhu","year":"2025","unstructured":"Zhu\u00a0J, Shen\u00a0K, Su\u00a0Q et\u00a0al (2025) Metabolic reprogramming and immunosenescence in colorectal cancer: mechanisms and therapeutic implications. Front Cell Dev Biol 13:1662464","journal-title":"Front Cell Dev Biol"},{"key":"1757_CR50","unstructured":"(2022) 2035 werden in Deutschland 4 Millionen mehr ab 67-J\u00e4hrige leben. https:\/\/www.destatis.de\/DE\/Presse\/Pressemitteilungen\/2022\/12\/PD22_511_124.html. Accessed 1.12.2025"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-026-01757-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-026-01757-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-026-01757-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:03:20Z","timestamp":1777039400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-026-01757-x"}},"subtitle":["Vom Tumormikromilieu \u00fcber translationale Ans\u00e4tze zum klinischen Ansprechen","From the tumor microenvironment to translational approaches and clinical response"],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1757"],"URL":"https:\/\/doi.org\/10.1007\/s00106-026-01757-x","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.H.L.\u00a0K\u00fcrten macht folgende Angaben: Reisekosten: Merck Sharp & Dohme (MSD). T.\u00a0Peis, L.\u00a0Boosfeld, M.\u00a0Peis und S.\u00a0Lang geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}